Brevan Howard Capital Management’s Insulet PODD Stock Holding History

Brevan Howard Capital Management’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.8M	Sell	11,814 -9,760	-45%	-$1.63M	0.01%	766
2026 Q1	$4.53M	Buy	21,574 +18,212	+542%	+$4.58M	0.04%	267
2025 Q4	$956K	Buy	3,362 +267	+9%	+$83.5K	0.01%	792
2025 Q3	$956K	Buy	3,095 +2,050	+196%	+$642K	﹤0.01%	922
2025 Q2	$328K	Buy	+1,045	New	+$302K	﹤0.01%	1512
2025 Q1	–	Sell	-1,168	Closed	-$305K	–	1393
2024 Q4	$305K	Buy	+1,168	New	+$294K	﹤0.01%	769
2024 Q3	–	Sell	-2,576	Closed	-$520K	–	1370
2024 Q2	$520K	Sell	2,576 -693	-21%	-$125K	﹤0.01%	592
2024 Q1	$560K	Sell	3,269 -1,323	-29%	-$247K	0.01%	422
2023 Q4	$996K	Buy	4,592 +3,215	+233%	+$551K	0.01%	235
2023 Q3	$220K	Buy	+1,377	New	+$308K	﹤0.01%	309

Other funds holding PODD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Brevan Howard Capital Management's PODD Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Insulet (PODD) stake by 45% in Q2 2026, selling an estimated $1.63M and leaving 11,814 shares worth $1.8M. The position accounts for 0.01% of the portfolio, ranked #766.

Brevan Howard Capital Management first reported a position in PODD in Q3 2023 and has held it in 10 quarters since. The position peaked at $4.53M in Q1 2026. 731 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

Brevan Howard Capital Management held 11,814 shares of Insulet worth $1.8M as of Q2 2026.
Brevan Howard Capital Management sold 9,760 Insulet shares in Q2 2026, an estimated $1.63M.
Insulet made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #766 holding.
Brevan Howard Capital Management first reported a position in Insulet in Q3 2023 and has held it in 10 quarters since.
Brevan Howard Capital Management's Insulet position peaked at $4.53M in Q1 2026.
731 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.